PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE
NCT05022914 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2021-08-26
Summary
This observational study was designed to evaluate progression free survival after PSMA-PET/CT based salvage approach for patients affected by biochemical relapse after radical prostatectomy.
Conditions
- Prostate Cancer
- Biochemical Relapse Fo Malignant Neoplasm of Prostate
- Prostate Adenocarcinoma
- Prostate Cancer Recurrent
Sponsors & Collaborators
-
Azienda Ospedaliero-Universitaria Careggi
lead OTHER
Principal Investigators
-
Lorenzo Livi, Prof. · Azienda Ospedaliero-Universitaria Careggi
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-19
- Primary Completion
- 2024-01-19
- Completion
- 2027-01-19
Countries
- Italy
Study Locations
More Related Trials
-
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
NCT04742361 ·Status: COMPLETED ·Phase: PHASE3
-
68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically Treated
NCT02920229 ·Status: COMPLETED ·Phase: NA
-
Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer
NCT05328505 ·Status: RECRUITING ·Phase: NA
-
PSMA Response in Metastasized Hormone Sensitive Prostate Cancer
NCT05161728 ·Status: RECRUITING ·Phase: NA
-
Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s)
NCT04271579 ·Status: RECRUITING ·Phase: NA
-
PSMA PET/CT vs. mpMRI in Patients With a High Suspicion of Prostate Cancer: a Head to Head, Parallel, Prospective Trial
NCT05297162 ·Status: UNKNOWN ·Phase: NA
-
PSMA-PET Guided Radiotherapy
NCT03525288 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence
NCT04102553 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed
NCT04462926 ·Status: UNKNOWN ·Phase: NA
-
An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer
NCT04978675 ·Status: COMPLETED ·Phase: PHASE1
-
Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early Stage
NCT04116086 ·Status: UNKNOWN ·Phase: NA
-
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
NCT04700332 ·Status: RECRUITING ·Phase: PHASE2
-
PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment
NCT04298112 ·Status: COMPLETED
-
Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor
NCT05761366 ·Status: RECRUITING ·Phase: PHASE2
-
PSMA-PET/CT Registry
NCT05709535 ·Status: TERMINATED
-
PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy
NCT04642027 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluating the Role of Both PSMA and 64Cu-PET/CT Total Body in Patients With Locally Relapsed Prostate Cancer
NCT04703543 ·Status: COMPLETED ·Phase: NA
-
Identification of Predictive Biomarkers
NCT04324983 ·Status: COMPLETED ·Phase: NA
-
PROspective Multicenter Observational Study on Elective Pelvic Nodes Irradiation.
NCT03340272 ·Status: UNKNOWN
-
PSMA PET/CT for Assessment of Recurrent Prostate Cancer
NCT02899312 ·Status: ACTIVE_NOT_RECRUITING
-
Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer
NCT02825875 ·Status: COMPLETED
-
PSMA PET for Surveillance After Focal Therapy
NCT07115914 ·Status: RECRUITING ·Phase: NA
-
Genetics of Prostate Cancer in Young Patients
NCT06714227 ·Status: COMPLETED
-
Prognostic Study of Via Dynamic Change of PCA3 mRNA in Drainage Fluid After Radical Prostatectomy
NCT06707961 ·Status: NOT_YET_RECRUITING
-
GUidance In Prostate Cancer DEtection With 18F-PSMA-1007-PET/MRI and Targeted Biopsies
NCT07258056 ·Status: RECRUITING ·Phase: NA